AMYRA Biotech is ready to partner and scale-up its novel enzymatic treatments for non-celiac gluten sensitivity, and celiac disease.
Produced by AMYRA in cooperation with: In recent years, public awareness of gluten-related disorders has become universal. Non-celiac gluten sensitivity (NCGS) and celiac disease (CeD) are two clinically distinct gluten-related disorders that constitute a major public health issue. During the digestion of gluten, relatively long fragments of digestion-resistant, proline-rich peptides are formed. These peptides, known …
